|1.||Wang, Guo-Cai: 2 articles (11/2015 - 03/2014)|
|2.||Chung, Hau Yin: 2 articles (11/2015 - 03/2014)|
|3.||Li, Yao-Lan: 2 articles (11/2015 - 03/2014)|
|4.||Li, Man-Mei: 2 articles (11/2015 - 03/2014)|
|5.||Xu, Jiao-Jiao: 2 articles (11/2015 - 03/2014)|
|6.||Ho, Chi-Tang: 2 articles (11/2014 - 10/2002)|
|7.||Lin, Jen-Kun: 2 articles (01/2007 - 10/2002)|
|8.||Boterberg, Tom: 2 articles (03/2005 - 01/2002)|
|9.||Depypere, Herman T: 2 articles (03/2005 - 01/2002)|
|10.||Manthey, John A: 2 articles (05/2004 - 02/2004)|
|1.||Breast Neoplasms (Breast Cancer)
01/01/2012 - "Previous studies showed that tangeretin suppressed the growth of T47D breast cancer cells by inhibiting ERK phosphorylation. "
02/01/2015 - "Hence, we strongly suggest that tangeretin is effective and efficient candidate for the treatment of experimental breast cancer."
11/01/2014 - "Citrus polymethoxyflavone tangeretin (5,6,7,8,4'-pentamethoxyflavone, TAN) displays multiple biological activities, but previous reports showed that TAN failed to induce MCF-7 human breast cancer cells apoptosis. "
11/01/2014 - "Pro-apoptotic effects of the novel tangeretin derivate 5-acetyl-6,7,8,4'-tetramethylnortangeretin on MCF-7 breast cancer cells."
09/01/2000 - "Tangeretin, a molecule present in citrus fruits and in certain 'natural' menopausal medications, is an effective tumour growth and invasion inhibitor in vitro of human MCF 7/6 breast cancer cells. "
|2.||Body Weight (Weight, Body)
02/01/2015 - "We have recorded the body weight, tumor weights, tumor volume and antitumor activity of tangeretin in the experimental animals. "
09/01/2000 - "The present study was carried out in order to investigate the in vivo biotransformation and excretion of the flavone, tangeretin, found in citrus fruits, by analysing urine and faeces samples from rats after repeated administration of 100 mg/kg body weight/day tangeretin. "
02/01/2015 - "Group I was control, Group II was DMBA-induced breast cancer-bearing rats, Group III was tangeretin pre-treated (50 mg/kg body weight for 30 days orally) breast cancer-bearing animals, Group IV was tangeretin post-treated (50 mg/kg body weight for 30 days orally) and Group V was tangeretin (50 mg/kg body weight) alone treated animals. "
05/15/2014 - "The daily oral administration of tangeretin (100mg/kg body weight) to diabetic rats for 30 days resulted in a significant reduction in the levels of plasma glucose, glycosylated hemoglobin (HbA1c) and increase in the levels of insulin and hemoglobin. "
11/04/2015 - "Moreover, a luminex assay indicated tangeretin relieved RSV-induced lung inflammation by attenuating interleukin (IL)-1β secretion. "
11/04/2015 - "This study demonstrates that tangeretin inhibited RSV replication and RSV-induced lung inflammation in vivo and may be useful in preventing and treating RSV infections and inflammation. "
12/01/2009 - "Thus, effectiveness of tangeretin combinations, as a promising modality in the treatment of resistant cancers, warrants systematic clinical studies."
11/01/2014 - "Remarkably, tangeretin treatment controlled the growth of cancer cells which was clearly evidenced by morphological and histological analysis. "
04/01/2011 - "The mechanisms by which the dietary compound tangeretin has anticancer effects may include acting as a prodrug, forming an antiproliferative product in cancer cells. "
12/01/2009 - "Tangeretin is a citrus flavonoid known to inhibit cancer cell proliferation. "
03/14/2005 - "Tangeretin is a methoxyflavone from citrus fruits, which inhibits growth of human mammary cancer cells and cytolysis by natural killer cells. "
|8.||Glycosylated Hemoglobin A (Glycosylated Hemoglobin)
|3.||Heterologous Transplantation (Xenotransplantation)
|4.||Drug Therapy (Chemotherapy)